NCT00260208 - Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus | Biotech Hunter

Enrollment

361

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

September 30, 2010

Conditions

Liver TransplantHepatitis C

Interventions

DRUG

Cyclosporine A

Initial dose of 10-15mg/kg/day either orally, via a nasogastric (NG) tube or intravenously (i.v.) within the first 24 hours post-transplantation.

DRUG

Tacrolimus

Tacrolimus was administered within the first 24 hours post-transplantation at an initial dose of 0.1-0.15 mg/kg/day in 2 divided doses either orally or via a nasogastric (NG) tube or intravenously (i.v).

Trial Locations (2)

8091

Novartis Investigational Site, Zurich

Unknown

Novartis Investigative Site, East Hanover